Charmaine Lykins

Charmaine Lykins is an accomplished executive in the pharmaceutical industry, currently serving as Chief Commercial Officer and Commercial Strategy Advisor at MapLight Therapeutics, Inc. since April 2023. Prior roles include Chief Commercial Officer at Karuna Therapeutics from November 2021 to January 2023, and Senior Vice President of Global Product Planning and Chief Marketing Officer at Acadia Pharmaceuticals from February 2018 to November 2021. Lykins has extensive experience in marketing and product strategy, having held significant positions at Lundbeck, Sunovion Pharmaceuticals, Xanodyne Pharmaceuticals, and Eli Lilly and Company, covering areas including schizophrenia, depression, and pain management. Educational qualifications include an MBA in International Business from the University of South Carolina Darla Moore School of Business and a BS in Chemistry from Ball State University.